Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» multiple sclerosis
multiple sclerosis
Novartis’s Big Plans for Multiple Sclerosis
WSJ Online
Mon, 08/17/09 - 11:29 am
Novartis
MS
multiple sclerosis
Bayer
Novartis gets FDA approval for MS drug
Marketwatch
Mon, 08/17/09 - 09:09 am
Novartis
FDA
MS
multiple sclerosis
Extavia
Another Blow for Biogen's Tysabri
Yahoo/Zacks.com
Wed, 07/29/09 - 03:47 pm
PML
Tysabri
MS
multiple sclerosis
Elan
Biogen Idec
Lilly, BioMS scrap MS drug after trial fails
Reuters
Tue, 07/28/09 - 09:22 am
Eli Lilly
BioMS Medical
MS
multiple sclerosis
drug trials
Does Tysabri Hold the Key to a JNJ Purchase of Biogen Idec?
WSJ Online
Mon, 07/20/09 - 08:00 pm
Tysabri
JNJ
Biogen Idec
M&A
MS
multiple sclerosis
Biogen wins fast-track clearance from FDA
Bizjournals.com
Wed, 07/8/09 - 08:33 pm
Biogen Idec
FDA
MS
multiple sclerosis
Biogen Idec receives expedited FDA review for potential multiple sclerosis relapse drug
Yahoo/AP
Wed, 07/8/09 - 10:15 am
Biogen Idec
MS
multiple sclerosis
FDA
Biogen enrolls patients in new MS trial
Bizjournals.com
Tue, 06/23/09 - 08:34 am
Biogen Idec
drug trials
MS
multiple sclerosis
Biogen reports 9th case of rare brain infection in Tysabri patients since 2006 reintroduction
Yahoo/AP
Mon, 06/22/09 - 11:39 am
Biogen Idec
Tysabri
PML
MS
multiple sclerosis
Merck KGaA Pill Cuts MS Relapse Risk in Half, With Side Effects
Bloomberg
Thu, 04/30/09 - 07:25 am
Merck KGaA
multiple sclerosis
MS
cladribine
New Data Illustrate Novel Mechanism of Action of Laquinimod, an Oral Compound for the Treatment of Multiple Sclerosis
Yahoo
Tue, 04/28/09 - 09:32 am
Teva Pharmaceuticals
MS
multiple sclerosis
laquinimod
Novartis Drug Heralds Era of New Multiple Sclerosis Therapies
Bloomberg
Mon, 04/27/09 - 11:46 am
Novartis
MS
multiple sclerosis
Biogen's Tysabri Reports 6th Case
Yahoo/Zacks.com
Mon, 04/20/09 - 10:54 am
Biogen Idec
Tysabri
MS
multiple sclerosis
PML
Biogen Idec Receives Approval for TYSABRI High Titer Production
Yahoo
Thu, 04/16/09 - 08:33 am
Biogen Idec
Tysabri
FDA
MS
multiple sclerosis
Biogen Idec reports 1Q results after the market closes, Wall Street focuses on MS drugs
Yahoo/AP
Thu, 04/16/09 - 07:56 am
Biogen Idec
earnings
MS
multiple sclerosis
Tysabri
FDA Won't Review Acorda's MS Drug
TheStreet.com
Tue, 03/31/09 - 08:05 am
FDA
MS
multiple sclerosis
Acorda Therapeutics
Fampridine-SR
Teva gets expanded FDA approval for MS drug
Yahoo/AP
Tue, 03/3/09 - 09:16 pm
Teva Pharmaceuticals
FDA
multiple sclerosis
MS
Copaxone
Teva Seeks Deals to Deepen Branded Business in ‘Niche’ Diseases
Bloomberg
Tue, 02/24/09 - 08:42 am
Teva Pharmaceuticals
MS
multiple sclerosis
MS Prize of $1.3 Billion Spurs Merck KGaA, Novartis
Bloomberg
Fri, 02/13/09 - 12:01 pm
MS
multiple sclerosis
Merck KGaA
Novartis
Teva Pharmaceutical Industries, Active Biotech drug candidate gets expedited review by FDA
Yahoo/AP
Fri, 02/13/09 - 07:21 am
Teva Pharmaceuticals
FDA
Active Biotech
laquinimod
MS
multiple sclerosis
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
next ›
last »